Adma Biologics | ADMA - Operating Profit

Stock Price
14.77
Daily Change
-0.10 -0.67%
Monthly
-8.26%
Yearly
-24.83%
Q1 Forecast
14.69

Adma Biologics reported $62.75M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Adma Biologics USD 62.75M 11.74M Dec/2025
Alnylam Pharmaceuticals USD 29.4M 59.36M Dec/2025
BioCryst Pharmaceuticals USD 260.38M 230.79M Dec/2025
Minerva Neurosciences USD -21.85M 17.48M Dec/2024
Novavax USD 20.94M 100.32M Dec/2025
Omeros USD -35.41M 23.75M Sep/2024
Takeda JPY 168.82B 479.89B Dec/2025